Corrigendum for “Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib” [Acta Biomaterialia, 2023, 159, 237-246](S1742706123000569)(10.1016/j.actbio.2023.01.053)

Xiaorui Wang, Lei Zhao, Chenxi Wang, Leichen Wang, Haisi Wu, Xuejiao Song, Wenjun Wang, Huae Xu, Xiaochen Dong

科研成果: 期刊稿件 › 评论/辩论

指纹

探究 'Corrigendum for “Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib” [Acta Biomaterialia, 2023, 159, 237-246](S1742706123000569)(10.1016/j.actbio.2023.01.053)' 的科研主题。它们共同构成独一无二的指纹。

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions

Neuroscience

Engineering